It's good to read your optimistic interpretation of the new PR. As we are drawing very close to the new revenue figures, it will be of the greatest interest to see how the chart develops during the next 2-3 weeks. My personal conviction is that much will depend on the opportunities for quickly developing/expanding the compound pharmacy side, and also on just how rapidly matters will move in Hong Kong and China.